Streetbeat News

Stock Prices

STC

Keefe, Bruyette & Woods analyst Bose George has maintained a 'Market Perform' rating on Stewart Information Services (NYSE:STC) and increased the price target from $46 to $56.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:58 pm

RKT

Keefe, Bruyette & Woods analyst Bose George has maintained a 'Market Perform' rating on Rocket Companies (NYSE:RKT) and increased the price target from $9.25 to $10.75.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:57 pm

OPEN

Opendoor Technologies' stock (OPEN) is trading higher following an upgrade from Keefe, Bruyette & Woods, who raised their rating from Underperform to Market Perform and increased the price target from $1.65 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:55 pm

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SLV

SPY

TSLA

USO

The CBOE Volatility Index (VIX) has dropped to its lowest level since November 2019, indicating reduced market fear. The Producer Price Index (PPI) data came in better than consensus, with both headline and core PPI at 0.0% versus expectations of 0.1% and 0.2%, respectively. The Arora Report suggests that deflation in China is aiding the reduction of inflation in the U.S. The Federal Open Market Committee (FOMC) rate decision and Chair Powell's press conference are anticipated, with investors betting on multiple rate cuts in 2024. Argentina has devalued its currency by 54%, and foreign investors are optimistic about austerity measures. Early trade money flows are positive for AAPL, AMZN, GOOG, MSFT, SPY, and QQQ, but negative for NVDA, META, and TSLA. Gold and oil trading are active, with the momo crowd buying gold and selling oil. Bitcoin has stabilized above $40,000, with promoters optimistic post-Fed announcement.

Portfolio Pulse from The Arora Report

December 13, 2023 | 3:50 pm

ARRW

Benchmark analyst Matthew Harrigan has initiated coverage on Arrowroot Acquisition (NASDAQ:ARRW) with a Buy rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:50 pm

ZLAB

Zai Lab's stock is up following the inclusion of its drugs VYVGART, NUZYRA, and ZEJULA in China's 2023 National Reimbursement Drug List. This addition is likely to increase the accessibility and sales of these drugs in the Chinese market, potentially boosting Zai Lab's revenues.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:49 pm

LGND

Benchmark analyst Robert Wasserman has reiterated a Buy rating on Ligand Pharmaceuticals (NASDAQ:LGND) and maintained a $95 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:47 pm

NLY

Keefe, Bruyette & Woods analyst Bose George has maintained an Outperform rating on Annaly Capital Management (NYSE:NLY) and increased the price target from $17 to $21.5.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:47 pm

CURLF

TSNDF

Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) will begin trading its subordinate voting shares on the Toronto Stock Exchange (TSX) under the ticker symbol 'CURA' starting December 14. The company will mark the occasion by ringing the opening bell at TSX. The listing on TSX is expected to provide Curaleaf with greater access to global financial institutions and increase stock liquidity. Curaleaf's shares will be delisted from the Canadian Securities Exchange (CSE) after market close on December 13. The move follows TerrAscend Corp. (TSX:TSND) (OTCQX:TSNDF), another multi-state operator, which secured a TSX listing earlier in 2023.

Portfolio Pulse from Jelena Martinovic

December 13, 2023 | 3:42 pm

NXTP

NextPlay Technologies shares have resumed trading after a temporary halt. The resumption of trading allows investors to buy and sell NextPlay Technologies stock once again.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 3:38 pm